Baker Bros. Advisors as of June 30, 2016
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 135 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 19.7 | $1.9B | 24M | 79.98 | |
Seattle Genetics | 18.3 | $1.7B | 43M | 40.41 | |
Abbvie (ABBV) | 9.3 | $890M | 14M | 61.91 | |
ACADIA Pharmaceuticals (ACAD) | 8.3 | $796M | 25M | 32.46 | |
Alexion Pharmaceuticals | 8.0 | $764M | 6.5M | 116.76 | |
Incyte Corp Ltd conv | 4.9 | $467M | 275M | 1.70 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 4.5 | $433M | 259M | 1.67 | |
BioMarin Pharmaceutical (BMRN) | 3.9 | $374M | 4.8M | 77.80 | |
Genomic Health | 3.7 | $354M | 14M | 25.89 | |
Dbv Technologies S A (DBVT) | 1.9 | $180M | 5.5M | 32.62 | |
Xenoport Inc convertible security | 1.0 | $98M | 100M | 0.98 | |
Acorda Therapeutics | 1.0 | $93M | 3.7M | 25.51 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.9 | $85M | 22M | 3.79 | |
Cerus Corporation (CERS) | 0.9 | $85M | 14M | 6.24 | |
Spark Therapeutics | 0.7 | $67M | 1.3M | 51.13 | |
Acorda Therap note 1.75% 6/15 | 0.7 | $67M | 77M | 0.87 | |
Bellicum Pharma | 0.7 | $63M | 4.9M | 12.96 | |
Beigene (BGNE) | 0.6 | $57M | 1.9M | 29.80 | |
Heron Therapeutics (HRTX) | 0.5 | $52M | 2.9M | 18.05 | |
Aquinox Pharmaceuticals | 0.5 | $51M | 7.8M | 6.62 | |
Clovis Oncology Inc note 2.500% 9/1 | 0.5 | $52M | 73M | 0.71 | |
Invitae (NVTA) | 0.5 | $48M | 6.6M | 7.39 | |
BioCryst Pharmaceuticals (BCRX) | 0.5 | $43M | 15M | 2.84 | |
Neurocrine Biosciences (NBIX) | 0.4 | $41M | 895k | 45.45 | |
Versartis | 0.3 | $30M | 2.7M | 11.06 | |
Exelixis Inc cnv | 0.3 | $30M | 20M | 1.48 | |
XenoPort | 0.3 | $25M | 3.5M | 7.04 | |
Advanced Accelerat spon ads each rep 2 ord | 0.3 | $25M | 833k | 30.23 | |
Sangamo Biosciences (SGMO) | 0.2 | $24M | 4.1M | 5.79 | |
Intra Cellular Therapies (ITCI) | 0.2 | $24M | 609k | 38.82 | |
Intellia Therapeutics (NTLA) | 0.2 | $23M | 1.1M | 21.35 | |
Exelixis (EXEL) | 0.2 | $20M | 2.6M | 7.81 | |
Medivation | 0.2 | $20M | 330k | 60.30 | |
Achillion Pharmaceuticals | 0.2 | $19M | 2.5M | 7.80 | |
Progenics Pharmaceuticals | 0.2 | $17M | 4.0M | 4.22 | |
Novavax | 0.2 | $17M | 2.4M | 7.27 | |
Halozyme Therapeutics (HALO) | 0.2 | $16M | 1.8M | 8.63 | |
Xencor (XNCR) | 0.2 | $17M | 872k | 18.99 | |
Array BioPharma | 0.2 | $15M | 4.3M | 3.56 | |
Derma Sciences | 0.2 | $15M | 3.8M | 3.94 | |
Insmed (INSM) | 0.2 | $15M | 1.5M | 9.86 | |
Corsicanto Ltd conv bnd | 0.2 | $15M | 15M | 1.02 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.2 | $15M | 27M | 0.56 | |
Foamix Pharmaceuticals | 0.1 | $14M | 2.2M | 6.35 | |
Galapagos Nv- (GLPG) | 0.1 | $14M | 260k | 55.47 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $14M | 12M | 1.11 | |
Tg Therapeutics (TGTX) | 0.1 | $12M | 2.0M | 6.06 | |
Bluebird Bio (BLUE) | 0.1 | $13M | 294k | 43.29 | |
Mirati Therapeutics (MRTX) | 0.1 | $12M | 2.3M | 5.46 | |
Idera Pharmaceuticals | 0.1 | $11M | 7.0M | 1.53 | |
Alkermes (ALKS) | 0.1 | $11M | 250k | 43.22 | |
Alcobra | 0.1 | $11M | 2.3M | 4.49 | |
ImmunoGen (IMGN) | 0.1 | $9.3M | 3.0M | 3.08 | |
Macrogenics (MGNX) | 0.1 | $9.8M | 364k | 26.99 | |
Dermira | 0.1 | $9.5M | 326k | 29.25 | |
Ascendis Pharma A S (ASND) | 0.1 | $9.9M | 746k | 13.27 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $8.8M | 73k | 119.27 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $8.7M | 208k | 41.90 | |
Merus N V (MRUS) | 0.1 | $9.0M | 1.1M | 7.99 | |
Zogenix | 0.1 | $8.1M | 1.0M | 8.05 | |
Aimmune Therapeutics | 0.1 | $7.3M | 674k | 10.82 | |
Dimension Therapeutics | 0.1 | $7.5M | 1.3M | 6.00 | |
Sage Therapeutics (SAGE) | 0.1 | $6.8M | 224k | 30.13 | |
Vitae Pharmaceuticals | 0.1 | $6.9M | 638k | 10.79 | |
Akari Therapeutics | 0.1 | $6.7M | 497k | 13.49 | |
Aerie Pharmaceuticals | 0.1 | $5.3M | 299k | 17.60 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $5.4M | 111k | 48.91 | |
Concert Pharmaceuticals I equity | 0.1 | $5.3M | 470k | 11.23 | |
Alder Biopharmaceuticals | 0.1 | $5.4M | 217k | 24.97 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $6.0M | 1.2M | 4.84 | |
Natera (NTRA) | 0.1 | $5.4M | 450k | 12.06 | |
Arrowhead Pharmaceuticals (ARWR) | 0.1 | $5.4M | 1.0M | 5.32 | |
Medgenics | 0.1 | $4.9M | 881k | 5.55 | |
Minerva Neurosciences | 0.1 | $5.2M | 508k | 10.21 | |
Neuroderm Ltd F | 0.1 | $5.0M | 305k | 16.25 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $3.6M | 5.1M | 0.71 | |
Endocyte | 0.0 | $3.6M | 1.1M | 3.21 | |
Seres Therapeutics (MCRB) | 0.0 | $3.6M | 125k | 29.05 | |
Syros Pharmaceuticals | 0.0 | $3.7M | 205k | 18.15 | |
Osiris Therapeutics | 0.0 | $2.5M | 499k | 5.09 | |
Curis | 0.0 | $3.1M | 2.0M | 1.56 | |
Sunesis Pharmaceuticals | 0.0 | $2.4M | 4.5M | 0.55 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $2.6M | 3.0M | 0.85 | |
Trevena | 0.0 | $2.8M | 450k | 6.30 | |
Glycomimetics (GLYC) | 0.0 | $2.8M | 381k | 7.27 | |
Ignyta | 0.0 | $3.1M | 571k | 5.42 | |
Adamas Pharmaceuticals | 0.0 | $2.6M | 173k | 15.14 | |
Loxo Oncology | 0.0 | $3.2M | 138k | 23.18 | |
Juno Therapeutics | 0.0 | $3.1M | 80k | 38.44 | |
Proteon Therapeutics | 0.0 | $2.4M | 299k | 8.03 | |
Nabriva Therapeutics | 0.0 | $2.6M | 350k | 7.50 | |
Selecta Biosciences (RNAC) | 0.0 | $2.5M | 179k | 13.99 | |
Amarin Corporation (AMRN) | 0.0 | $1.7M | 802k | 2.16 | |
Cytrx | 0.0 | $1.5M | 660k | 2.23 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $1.7M | 75k | 22.06 | |
Mast Therapeutics | 0.0 | $1.8M | 3.9M | 0.47 | |
D Stemline Therapeutics | 0.0 | $2.3M | 334k | 6.77 | |
Epizyme | 0.0 | $2.4M | 233k | 10.24 | |
Ophthotech | 0.0 | $1.8M | 36k | 51.03 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $1.5M | 217k | 6.71 | |
Uniqure Nv (QURE) | 0.0 | $1.7M | 230k | 7.37 | |
Mediwound Ltd cmn | 0.0 | $1.8M | 226k | 7.89 | |
Aurinia Pharmaceuticals (AUPH) | 0.0 | $2.1M | 712k | 2.98 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.3M | 3.4M | 0.67 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $1.9M | 212k | 8.98 | |
Invivo Therapeutics Hldgs | 0.0 | $2.3M | 400k | 5.78 | |
Aeglea Biotherapeutics | 0.0 | $2.0M | 404k | 4.86 | |
Synta Pharmaceuticals | 0.0 | $526k | 2.0M | 0.26 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $629k | 11k | 55.47 | |
BioDelivery Sciences International | 0.0 | $496k | 210k | 2.36 | |
Palatin Technologies | 0.0 | $902k | 2.1M | 0.44 | |
Gw Pharmaceuticals Plc ads | 0.0 | $1.4M | 15k | 91.60 | |
Acceleron Pharma | 0.0 | $977k | 29k | 33.96 | |
Five Prime Therapeutics | 0.0 | $796k | 19k | 41.36 | |
Aldeyra Therapeutics (ALDX) | 0.0 | $808k | 142k | 5.69 | |
Scynexis | 0.0 | $1.0M | 468k | 2.17 | |
Immune Design | 0.0 | $1.2M | 149k | 8.16 | |
Assembly Biosciences (ASMB) | 0.0 | $1.4M | 250k | 5.55 | |
Tenax Therapeutics | 0.0 | $1.1M | 420k | 2.56 | |
Affimed Therapeutics B V (AFMD) | 0.0 | $992k | 400k | 2.48 | |
Dynavax Technologies (DVAX) | 0.0 | $1.1M | 75k | 14.59 | |
Cellectis S A (CLLS) | 0.0 | $1.3M | 50k | 26.60 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $815k | 100k | 8.15 | |
Arbutus Biopharma (ABUS) | 0.0 | $628k | 181k | 3.48 | |
Ritter Pharmaceuticals | 0.0 | $612k | 400k | 1.53 | |
Ionis Pharmaceuticals (IONS) | 0.0 | $1.3M | 57k | 23.29 | |
Windtree Therapeutics | 0.0 | $492k | 255k | 1.93 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $83k | 13k | 6.26 | |
Chemocentryx | 0.0 | $220k | 49k | 4.48 | |
Chimerix (CMRX) | 0.0 | $453k | 115k | 3.93 | |
Foundation Medicine | 0.0 | $390k | 21k | 18.67 | |
La Jolla Pharmaceuticl Com Par | 0.0 | $220k | 14k | 16.00 | |
Achaogen | 0.0 | $379k | 100k | 3.79 | |
Biotime Inc wts oct 1 18 | 0.0 | $9.0k | 20k | 0.45 | |
Pronai Therapeutics | 0.0 | $398k | 200k | 1.99 |